Cardio-Oncology

Cardio-oncology is the intersection of heart failure conditions in patients who have been treated for cancer. New insights into however cancer therapies impact cardiovascular physiological condition and long-run effects on cancer survivors. In view of trends, similarly because the cardiovascular toxicity potential of radiation and therapy, cancer patients square measure exposed to vas morbidity and mortality over ever before. Anticancer therapies will cause important injury to the vasculature, leading to angina, acute coronary syndromes (ACS), stroke, critical limb ischemia, arrhythmias, and heart failure (HF), independently from the direct myocardial or pericardial damage that might occur. Moreover, cancer is mostly related to a hypercoagulable state, that will increase the danger of acute thrombotic events.

 

    Related Conference of Cardio-Oncology

    December 01-02, 2022

    International Meeting on Fluid Dynamics & Fluid Mechanics

    Vancouver, Canada
    December 05-06, 2022

    World Summit on Biosensor and Bioelectronics

    Paris, France
    December 07-08, 2022

    24th International Conference on Superbugs

    Prague, Czech Republic
    December 12-13, 2022

    Global meet on Optoelectronics and Quantum Physics

    Paris, France
    February 20-21, 2023

    4th International Conference on Physics

    Paris, France
    February 23-24, 2023

    8th International Summit on Rehabilitation

    San Francisco, USA
    March 09-10, 2023

    6th International Congress on Physics

    London, UK
    June 14-15, 2023

    9th International Conference on Physics

    Edinburgh, Scotland
    November 27-28, 2023

    30th International Summit on AstroPhysics

    Philadelphia, USA

    Cardio-Oncology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in